A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of CMX157 and the amount
of CMX157 that reaches the blood stream, the manner in which the body processes CMX157 and
the time that it takes to eliminate CMX157 following one oral dose when given to healthy
volunteers.